Stocks and Investing Stocks and Investing
Thu, August 5, 2021

Patrick Donnelly Maintained (TXG) at Strong Buy with Decreased Target to $220 on, Aug 5th, 2021


Published on 2024-10-27 17:31:15 - WOPRAI, Patrick Donnelly
  Print publication without navigation


Patrick Donnelly of Citigroup, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Decreased Target from $240 to $220 on, Aug 5th, 2021.

Patrick, nor any peers, have made any analyst calls on TXG in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources